RU2009143963A - 4- (4-METHOXYPHENYLTIO) -2,5-DIOXO-2,5-DIHYDRO-1H-PIRRO-3-IL) -1H-INDOL-3-IL) BUTILKARBAMIMIMIDOTIOATE, METHOD FOR PRODUCING AND APPLICATION - Google Patents
4- (4-METHOXYPHENYLTIO) -2,5-DIOXO-2,5-DIHYDRO-1H-PIRRO-3-IL) -1H-INDOL-3-IL) BUTILKARBAMIMIMIDOTIOATE, METHOD FOR PRODUCING AND APPLICATION Download PDFInfo
- Publication number
- RU2009143963A RU2009143963A RU2009143963/04A RU2009143963A RU2009143963A RU 2009143963 A RU2009143963 A RU 2009143963A RU 2009143963/04 A RU2009143963/04 A RU 2009143963/04A RU 2009143963 A RU2009143963 A RU 2009143963A RU 2009143963 A RU2009143963 A RU 2009143963A
- Authority
- RU
- Russia
- Prior art keywords
- chemical compound
- indol
- dioxo
- dihydro
- lhta
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 8
- -1 4-methoxyphenylthio Chemical group 0.000 claims abstract 2
- 206010006187 Breast cancer Diseases 0.000 claims abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract 2
- 206010009944 Colon cancer Diseases 0.000 claims abstract 2
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 claims abstract 2
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 claims abstract 2
- BPMPPVUBRPXMNX-UHFFFAOYSA-N butyl carbamimidothioate Chemical compound CCCCSC(N)=N BPMPPVUBRPXMNX-UHFFFAOYSA-N 0.000 claims abstract 2
- 208000029742 colonic neoplasm Diseases 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 2
- 208000032839 leukemia Diseases 0.000 claims abstract 2
- 201000001441 melanoma Diseases 0.000 claims abstract 2
- 230000000771 oncological effect Effects 0.000 claims abstract 2
- 230000008506 pathogenesis Effects 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Индивидуальное химическое соединение ЛХТА-1833 (4-(1-(4-(4-метоксифенилтио)-2,5-диоксо-2,5-дигидро-1Н-пирро-3-ил)-1Н-индол-3-ил)бутил карбамимидотиоат). ! 2. Способ получения химического соединения согласно п.1. ! 3. Применение химического соединение ЛХТА-1833 соединения в терапии рака толстой кишки, рака молочной железы, меланомы, лейкоза и других онкологических заболеваний, в патогенезе которых участвуют серин-треониновые протеинкиназы. 1. Individual chemical compound LHTA-1833 (4- (1- (4- (4-methoxyphenylthio) -2,5-dioxo-2,5-dihydro-1H-pyrro-3-yl) -1H-indol-3- il) butyl carbamimidothioate). ! 2. A method of obtaining a chemical compound according to claim 1. ! 3. The use of the chemical compound LHTA-1833 compounds in the treatment of colon cancer, breast cancer, melanoma, leukemia and other oncological diseases, in the pathogenesis of which serine-threonine protein kinases are involved.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009143963/04A RU2441000C2 (en) | 2009-11-27 | 2009-11-27 | 4-(1-(4-(4-methoxyphenylthio)-2,5-dioxo-2,5-dihydro-1h-pyrro-3-yl)-1h-indol-3-yl)butylcarbamimidothioate and method for using it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009143963/04A RU2441000C2 (en) | 2009-11-27 | 2009-11-27 | 4-(1-(4-(4-methoxyphenylthio)-2,5-dioxo-2,5-dihydro-1h-pyrro-3-yl)-1h-indol-3-yl)butylcarbamimidothioate and method for using it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009143963A true RU2009143963A (en) | 2011-06-10 |
| RU2441000C2 RU2441000C2 (en) | 2012-01-27 |
Family
ID=44736201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009143963/04A RU2441000C2 (en) | 2009-11-27 | 2009-11-27 | 4-(1-(4-(4-methoxyphenylthio)-2,5-dioxo-2,5-dihydro-1h-pyrro-3-yl)-1h-indol-3-yl)butylcarbamimidothioate and method for using it |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2441000C2 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO308798B1 (en) * | 1993-12-07 | 2000-10-30 | Lilly Co Eli | Protein kinase C inhibitors, use of same for the manufacture of pharmaceuticals and pharmaceutical formulation comprising the same |
| US5545636A (en) * | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
| US6281356B1 (en) * | 1999-12-22 | 2001-08-28 | Hoffmann-La Roche Inc. | Substituted pyrroles |
| PE20020544A1 (en) * | 2000-11-07 | 2002-07-30 | Novartis Ag | INDOLYLMALEIMIDE DERIVATIVES |
| HRP20050991A2 (en) * | 2003-06-13 | 2006-09-30 | Janssen Pharmaceutica N.V. | Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
-
2009
- 2009-11-27 RU RU2009143963/04A patent/RU2441000C2/en active IP Right Revival
Also Published As
| Publication number | Publication date |
|---|---|
| RU2441000C2 (en) | 2012-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790678A1 (en) | Bicyclic Heteroaryl Compounds | |
| EA201200218A1 (en) | NEW BICYCLIC UREA COMPOUNDS | |
| EA201170154A1 (en) | DERIVATIVES OF PYRIDINOPIRIDINONES, METHOD OF THEIR RECEPTION AND APPLICATION IN THERAPY | |
| MX382352B (en) | HETEROARYL COMPOUNDS AND THEIR USES. | |
| EA201001359A1 (en) | HETEROCYCLIC COMPOUNDS AS CXCR2 INHIBITORS | |
| EA201100875A1 (en) | NEW PYRAZOL-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES | |
| ECSP088145A (en) | BICYCLIC DERIVATIVES AS INHIBITORS OF CINASA P38 | |
| CY1112595T1 (en) | AMIDOFINOXYZAZAZOLS USEFUL AS C-MET SUSPENSIONS | |
| MA32319B1 (en) | Triazine derivatives are useful as kinase inhibitors of mtor and ft3 | |
| EA201390633A1 (en) | NEW SUBSTANCES FOR REPEATED PROCESSED EPOXY RESINS | |
| EA200970402A1 (en) | TRIAZOLOPIRIDAZIN PROTEINKINASE MODULATORS | |
| EA201290642A1 (en) | CONNECTIONS AND METHODS | |
| EA201100992A1 (en) | CARBAZOLKARBOXAMIDE COMPOUNDS APPLICABLE AS KINASE INHIBITORS | |
| EA201071224A1 (en) | LIMK2 INHIBITORS, COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE | |
| MX2012005358A (en) | PROCEDURE FOR THE PREPARATION OF DABIGATRAN ETEXYLATE. | |
| EA200702363A1 (en) | NEW HISTAMINE H-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS | |
| MX346924B (en) | DIARILHIDANTOINE COMPOUNDS. | |
| EA201300610A1 (en) | HINAZOLINCARBOXAMIDASETIDINE | |
| EA201101330A1 (en) | SUBSTITUTED PYRIMIDINES INTENDED FOR CANCER TREATMENT | |
| EA201101060A1 (en) | NEW HERBICIDES | |
| EA201000395A1 (en) | 2-Alkylthio-2- | |
| EA201201677A1 (en) | DERIVATIVES OF HETEROARILIMIDAZOLONE AS JAK INHIBITORS | |
| EA201101148A1 (en) | NEW HERBICIDES | |
| EA201100517A1 (en) | METHOD OF OBTAINING DAGIGATRAN AND ITS INTERMEDIATE CONNECTIONS | |
| EA201001124A1 (en) | QUINOLINE DERIVATIVES AND THEIR APPLICATION AS FUNGICIDES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20121128 |
|
| NF4A | Reinstatement of patent |
Effective date: 20151227 |